May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Genotypes in Blue Cone Monochromacy
Author Affiliations & Notes
  • B. Wissinger
    Molecular Genetics Laboratory, University Eye Hospital, Tuebingen, Germany
  • M. Papke
    Molecular Genetics Laboratory, University Eye Hospital, Tuebingen, Germany
  • S. Tippmann
    Molecular Genetics Laboratory, University Eye Hospital, Tuebingen, Germany
  • S. Kohl
    Molecular Genetics Laboratory, University Eye Hospital, Tuebingen, Germany
  • BCM Clinical Study Group
    Molecular Genetics Laboratory, University Eye Hospital, Tuebingen, Germany
  • Footnotes
    Commercial Relationships  B. Wissinger, None; M. Papke, None; S. Tippmann, None; S. Kohl, None.
  • Footnotes
    Support  DFG KFO134, Foundation Fighting Blindness, Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4609. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B. Wissinger, M. Papke, S. Tippmann, S. Kohl, BCM Clinical Study Group; Genotypes in Blue Cone Monochromacy . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4609.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To study the molecular basis and prevalence of different mutations in the red/green opsin gene cluster in a large series of patients with blue cone monochromacy (BCM).

Methods: : The structure of the red/green opsin gene cluster was analyzed in 40 independent BCM patients by means of PCR amplification, PCR/RFLP, DNA sequencing and Southern Blot hybridizations. X chromosome inactivation assays were done for the methylation sensitive markers ARC and DXS6673E using DNA isolated from venous blood samples.

Results: : In 12 patients we found deletions of various sizes that encompass either the locus control region (LCR) or the LCR and parts of the opsin genes itself. Single red or red/green hybrid opsin genes that carry the known Cys203Arg mutations were present in 18 patients. However we observed considerable opsin gene sequence variability in this group which excludes a common founder mutation event. In addition we identified the Cys203Arg in 9 subjects with multiple opsin genes where all copies harbour this mutation. Finally we identified one patient with a single red opsin gene that carries a new nonsense mutation (W90X). In 4 carrier females with reduced visual function we were able to show preferential inactivation of the non–mutant X chromosome.

Conclusions: : The presence of the Cys203Arg mutation was the most prevalent cause of BCM that accounted for more than 2/3 of all cases in our sample. Yet there is considerable genetic heterogeneity in such cases with respect to opsin gene copy number and the identity of the mutated gene copy/copies. We therefore propose that unequal homologous recombination is the driving force for the multiple independent occurrence of this genotype. We also provide evidence that skewed X inactivation may result in reduced visual function in BCM carrier females.

Keywords: retinal degenerations: hereditary • color pigments and opsins • photoreceptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×